πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7265133

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7262205

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256294

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. Β· Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7250414

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244705

Polyacid glycopeptide derivatives

Theravance, Inc. Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7238709

Therapeutic carbamates

Theravance, Inc. Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7226946

Substituted phenol compounds useful for anesthesia and sedation

Theravance, Inc. Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7226950

Sodium channel modulators

Theravance, Inc. Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223783

Indolinone derivatives

Theravance, Inc. Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7217738

Ξ²2-adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208515

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208471

Glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7195876

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. Β· Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183292

Substituted pyrrolidine and related compounds

Theravance, Inc. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183323

Sodium channel modulators

Theravance, Inc. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7179794

Multivalent macrolide antibiotics

Theravance, Inc. Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173039

Protein kinase inhibitors

Theravance, Inc. Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7160984

Process for preparing glycopeptide derivatives

Theravance, Inc. Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7157554

Glycopeptide carboxy-saccharide derivatives

Theravance, Inc. Β· Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151115

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141671

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132422

Sodium channel modulators

Theravance, Inc. Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125892

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101964

Intermediate for preparing glycopeptide derivatives

Theravance, Inc. Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted